NARRF yields 2.23% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, NARRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NARRF + PFE for your $10,000?
Nagoya Railroad Co., Ltd., together with its subsidiaries, engages in the railroad business in Japan. It operates through Traffic, Transport, Real Estate, Leisure and Services, Distribution, and Aviation Services segments. The Traffic segment engages in the railroads, buses, and taxis related businesses. The Transport segment is involved in the truck and maritime transportation related businesses. The Real Estate segment develops and leases real estate properties; and offers building maintenance services. The Leisure and Services segment operates hotels and restaurants; and provides tourist facilities and travel related services. The Distribution segment engages in the operation of a department store; and distribution of other merchandise. The Aviation Services segment offers general aviation and flight catering related services. The company is also involved in the equipment maintenance, information processing, insurance agency, and other businesses. It operates the 437 kilometers of railroad network and 7.2 kilometers of tramway network that connects Aichi and Gifu prefectures. Nagoya Railroad Co., Ltd. was founded in 1894 and is headquartered in Nagoya, Japan.
Full NARRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.